Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1636 1637 1681
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17264734 | ANTIBIOTIC SUSCEPTIBILITY OF MICROORGANISMS AND RELATED MARKERS, COMPOSITIONS, METHODS AND SYSTEMS | Non-Final OA | California Institute of Technology |
| 17992674 | BLOOD DNA METHYLATION BIOMARKER DIAGNOSTIC TEST FOR ANXIETY AND DEPRESSIVE DISORDERS | Non-Final OA | Emory University |
| 17806932 | METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION | Final Rejection | ACADEMIA SINICA |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | Non-Final OA | Washington University |
| 17568854 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Non-Final OA | Natera, Inc. |
| 18678376 | DNA-BASED ADAPTOME PROFILING FOR MINIMAL RESIDUAL DISEASE QUANTIFICATION IN LYMPHOID MALIGNANCIES | Final Rejection | MILABORATORIES INC. |
| 17800718 | Medicine Containing USAG-1-Targeting RNA Molecule for Tooth Regeneration Therapy | Non-Final OA | Aichi Prefecture |
| 17028839 | MICROFLUIDIC SIPHONING ARRAY FOR NUCLEIC ACID QUANTIFICATION | Non-Final OA | Combinati Incorporated |
| 18156775 | MASS SPECTROMETRY-BASED KIT FOR ERYTHROCYTE BLOOD GROUP GENOTYPING | Non-Final OA | Shanghai Blood Center |
| 17427014 | METHODS FOR DETECTING LEGIONELLA | Final Rejection | Quest Diagnostics Investments LLC |
| 17997568 | MOLECULAR MARKER FOR EARLY PANCREATIC NEOPLASM DETECTION, DETECTION METHOD AND USE THEREOF | Non-Final OA | KANTE (SHENZHEN) BIOTECHNOLOGIES, ING |
| 17891034 | COMPOSITION, KIT FOR DETECTING MUTATIONS OF 2019 NOVELCORONAVIRUS AND USE THEREOF | Non-Final OA | SANSURE BIOTECH INC. |
| 17781480 | METHODS FOR IDENTIFYING MICROBES IN A CLINICAL AND NON-CLINICAL SETTING | Non-Final OA | Biomiris Capital Group B.V. |
| 17432721 | METHODS FOR IDENTIFYING AND IMPROVING T CELL MULTIPOTENCY | Final Rejection | St. Jude Children's Research Hospital |
| 17609294 | EXOSOME MICRORNA AS SCHIZOPHRENIA MARKER AND USE THEREOF | Non-Final OA | Minzu University of China |
| 17291407 | METHOD FOR DIAGNOSING A CANCER AND ASSOCIATED KIT | Non-Final OA | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCH MÉDICALE) |
| 17281071 | SECOND GENERATION SEQUENCING-BASED METHOD FOR DETECTING MICROSATELLITE STABILITY AND GENOME CHANGES BY MEANS OF PLASMA | Non-Final OA | Guangzhou Burning Rock DX Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy